slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7.100 KRW | +3,20% |
|
+1,14% | +25,44% |
2023 | DongKoo Bio & Pharma Co, Ltd. (KOSDAQ:A006620) kondigt een aandeleninkoop aan ter waarde van KRW 2.000 miljoen aan aandelen. | CI |
2023 | DongKoo Bio&Pharma Co., Ltd. keurt een terugkoopplan goed. | CI |
Vakgebied
Aantal werknemers: 355
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Medicine
99,6
%
| 194 434 | 99,7 % | 214 877 | 99,6 % | +10,51% |
Connection Adjustment
-1,2
%
| -1 275 | -0,7 % | -2 517 | -1,2 % | +97,43% |
Marketing Agency
1,1
%
| 1 119 | 0,6 % | 2 360 | 1,1 % | +110,99% |
Banking Service
0,4
%
| 710 | 0,4 % | 966 | 0,4 % | +36,10% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
98,6
%
| 189 466 | 97,4 % | 212 140 | 98,6 % | +11,97% |
Overseas
1,4
%
| 5 030 | 2,6 % | 2 924 | 1,4 % | -41,86% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yong-Joon Cho
CEO | Chief Executive Officer | 58 | - |
Yoon-Sik Kim
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
Yong-Woo Kim
BRD | Director/Board Member | 50 | - |
Do-Hyung Kim
BRD | Director/Board Member | 51 | - |
Byung-Chan Jung
SAM | Sales & Marketing | 51 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jae-Hong Park
BRD | Director/Board Member | 61 | - |
Yong-Joon Cho
CEO | Chief Executive Officer | 58 | - |
In-Su Mun
BRD | Director/Board Member | 59 | - |
Do-Hyung Kim
BRD | Director/Board Member | 51 | - |
Yong-Woo Kim
BRD | Director/Board Member | 50 | - |
Sung-Hwa Ha
BRD | Director/Board Member | 50 | - |
Yeon-Ju Lee
BRD | Director/Board Member | 48 | - |
Kyu-Jin Choi
BRD | Director/Board Member | 53 | - |
Eun-Ok Choi
BRD | Director/Board Member | 58 | - |
Yo-Chan Park
BRD | Director/Board Member | 62 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 28 464 992 | 15 444 605 ( 54,26 %) | 936 589 ( 3,290 %) | 54,26 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
D&D Pharmatech Co., Ltd.
2.91% | 305 360 | 2.91% | 6 285 625 $ |
841 443 | 2.96% | 4 083 994 $ | |
TS NEXGEN CO., LTD. 1.80% | 2 292 738 | 1.80% | 1 339 670 $ |
GENOME & COMPANY 0.66% | 100 000 | 0.66% | 657 976 $ |
Bedrijfsgegevens
DongKoo Bio & Pharm Co. Ltd.
14th Floor, M State Building 114 Beobwon-ro
05854, Seoul
+
http://www.dongkoo.co.kr![Adres DongKoo Bio & Pharma Co., Ltd.(A006620)](https://cdn.zonebourse.com/static/address/120974590.png)
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,44% | 140 mln. | |
+51,82% | 797 mld. | |
+40,42% | 628 mld. | |
+16,95% | 323 mld. | |
+9,49% | 300 mld. | |
+17,25% | 244 mld. | |
+0,37% | 223 mld. | |
+9,96% | 214 mld. | |
+5,30% | 163 mld. | |
-6,29% | 153 mld. |
- Beurs
- Aandelen
- Koers A006620
- Onderneming DongKoo Bio & Pharma Co., Ltd.